世界卫生组织《国际卫生条例》与新冠疫情的不确定性
WHO International Health Regulations (IHR) vs COVID-19 Uncertainty.
作者信息
Stuckelberger Astrid, Urbina Manuel
机构信息
WHO expert on IHR, Privat-Docent Global Health Institute, University of Geneva, Switzerland.
International public health and policy expert, National Academy of, Medicine of Mexico.
出版信息
Acta Biomed. 2020 May 11;91(2):113-117. doi: 10.23750/abm.v91i2.9626.
Abstract
One of WHO primary function is to control and monitor internationally the spread of infectious diseases of the common killers. After SARS-COV, the International Health Regulations (IHR) was adopted in 2005 by all 194 member states to set up national preparedness for an efficient "early alert and response system". COVID-19 is a novel virus with an unpredictable course and many uncertainties about its biological, clinical and epidemiological characteristics. COVID-19 is a game changer and calls for a revision of IHR as well as a more biological, clinical and community-cantered preparedness strategy.
摘要
世卫组织的主要职能之一是在国际上控制和监测常见致命传染病的传播。继严重急性呼吸综合征冠状病毒（SARS-CoV）之后，2005年所有194个成员国通过了《国际卫生条例》，以建立国家层面有效的“早期预警和应对系统”的防范机制。新型冠状病毒肺炎（COVID-19）是一种新型病毒，其病程不可预测，在生物学、临床和流行病学特征方面存在诸多不确定性。新型冠状病毒肺炎改变了局面，需要对《国际卫生条例》进行修订，并制定一种更以生物学、临床和社区为中心的防范战略。
相似文献
1
WHO International Health Regulations (IHR) vs COVID-19 Uncertainty.世界卫生组织《国际卫生条例》与新冠疫情的不确定性
Acta Biomed. 2020 May 11;91(2):113-117. doi: 10.23750/abm.v91i2.9626.
2
Has Global Health Law Risen to Meet the COVID-19 Challenge? Revisiting the International Health Regulations to Prepare for Future Threats.全球卫生法是否已奋起应对新冠疫情挑战？重温《国际卫生条例》以应对未来威胁。
J Law Med Ethics. 2020 Jun;48(2):376-381. doi: 10.1177/1073110520935354.
3
A state overview of COVID19 spread, interventions and preparedness.新冠疫情传播、干预措施及防范情况的国家概述。
Am J Emerg Med. 2020 Jul;38(7):1520-1523. doi: 10.1016/j.ajem.2020.04.020. Epub 2020 Apr 11.
4
Facing up to the uncertainties of COVID-19.直面新冠疫情的不确定性。
Nat Hum Behav. 2020 May;4(5):439. doi: 10.1038/s41562-020-0865-2.
5
Travel restrictions hampering COVID-19 response.旅行限制阻碍了对新冠疫情的应对。
Lancet. 2020 Apr 25;395(10233):1331-1332. doi: 10.1016/S0140-6736(20)30967-3.
6
From Mitigation to Containment of the COVID-19 Pandemic: Putting the SARS-CoV-2 Genie Back in the Bottle.从缓解到遏制新冠疫情：将新冠病毒这一精灵重新装入瓶中
JAMA. 2020 May 19;323(19):1889-1890. doi: 10.1001/jama.2020.6572.
7
Controlling the spread of COVID-19 in Sudan with limited resources: a unique community-engaged approach.在资源有限的情况下控制苏丹新冠疫情的传播：一种独特的社区参与方法。
East Mediterr Health J. 2020 Jun 24;26(6):636-637. doi: 10.26719/emhj.20.072.
8
Is the coronavirus airborne? Experts can't agree.新冠病毒是通过空气传播的吗？专家们对此尚无定论。
Nature. 2020 Apr;580(7802):175. doi: 10.1038/d41586-020-00974-w.
9
What is COVID-19?什么是新冠病毒？
Pediatr Dermatol. 2020 May;37(3):555-556. doi: 10.1111/pde.14218.
10
Treat COVID-19 as Though It Is Airborne: It May Be.将新冠病毒当作空气传播性病毒来对待：它可能就是。
AANA J. 2020 Apr;88(3):29-30.
引用本文的文献
1
Effect of the establishment of the Korea Centers for Disease Control and Prevention/Korea Disease Control and Prevention Agency from the perspective of global health security.从全球卫生安全角度看韩国疾病控制与预防中心/韩国疾病管理本部设立的影响
Glob Health Med. 2025 Apr 30;7(2):141-150. doi: 10.35772/ghm.2025.01015.
2
Analyzing self-evaluation capacity scores related to infectious disease control in International Health Regulations during the first year of COVID-19 pandemic.分析 COVID-19 大流行第一年《国际卫生条例》中与传染病控制相关的自我评估能力评分。
Sci Rep. 2022 Sep 2;12(1):15025. doi: 10.1038/s41598-022-19361-8.
3
COVID-19 persists: Current risk of a recurrence of the epidemic in China.新冠疫情仍在持续：中国当前疫情复发的风险
J Infect. 2022 Apr;84(4):579-613. doi: 10.1016/j.jinf.2021.12.021. Epub 2021 Dec 23.
4
Bio-safety and bio-security: A major global concern for ongoing COVID-19 pandemic.生物安全与生物安保：新冠疫情持续下的一项重大全球关切。
Saudi J Biol Sci. 2022 Jan;29(1):132-139. doi: 10.1016/j.sjbs.2021.08.060. Epub 2021 Aug 30.
5
Classification and analysis of outcome predictors in non-critically ill COVID-19 patients.非危重型 COVID-19 患者结局预测因素的分类与分析。
Intern Med J. 2021 Apr;51(4):506-514. doi: 10.1111/imj.15140. Epub 2021 Apr 9.
6
Health-care guidelines and policies during the COVID-19 pandemic in Mexico: A case of health-inequalities.墨西哥新冠疫情期间的医疗保健指南与政策：一个健康不平等的案例
Health Policy Open. 2021 Dec;2:100025. doi: 10.1016/j.hpopen.2020.100025. Epub 2020 Dec 15.
本文引用的文献
1
Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control Covid-19.无症状传播，当前控制新冠疫情策略的致命弱点。
N Engl J Med. 2020 May 28;382(22):2158-2160. doi: 10.1056/NEJMe2009758. Epub 2020 Apr 24.
2
Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries.新冠疫情背景下的卫生安全能力：对 182 个国家《国际卫生条例》年度报告数据的分析。
Lancet. 2020 Mar 28;395(10229):1047-1053. doi: 10.1016/S0140-6736(20)30553-5. Epub 2020 Mar 18.
3
WHO Declares COVID-19 a Pandemic.世界卫生组织宣布新冠疫情为大流行病。
Acta Biomed. 2020 Mar 19;91(1):157-160. doi: 10.23750/abm.v91i1.9397.
4
The International Health Regulations: The Governing Framework for Global Health Security.《国际卫生条例：全球卫生安全的管理框架》
Milbank Q. 2016 Jun;94(2):264-313. doi: 10.1111/1468-0009.12186. Epub 2016 May 11.
5
Revising the International Health Regulations: call for a 2017 review conference.修订《国际卫生条例》：呼吁召开2017年审查会议。
Lancet Glob Health. 2015 Jul;3(7):e352-3. doi: 10.1016/S2214-109X(15)00025-X. Epub 2015 May 7.
6
Worldly approaches to global health: 1851 to the present.世界卫生之道：1851 年至今。
Public Health. 2014 Feb;128(2):124-8. doi: 10.1016/j.puhe.2013.08.004. Epub 2014 Jan 7.
7
History and recent advances in coronavirus discovery.冠状病毒发现的历史与近期进展。
Pediatr Infect Dis J. 2005 Nov;24(11 Suppl):S223-7, discussion S226. doi: 10.1097/01.inf.0000188166.17324.60.
8
International efforts to control infectious diseases, 1851 to the present.1851年至今控制传染病的国际努力。
JAMA. 2004 Sep 22;292(12):1474-9. doi: 10.1001/jama.292.12.1474.
9
International infectious disease law: revision of the World Health Organization's International Health Regulations.国际传染病法：世界卫生组织《国际卫生条例》的修订
JAMA. 2004 Jun 2;291(21):2623-7. doi: 10.1001/jama.291.21.2623.
Zotero 插件